Intrathecal Therapies - 06/07/18
Résumé |
Intrathecal baclofen therapy is a well-established technique for spasticity management. This article briefly reviews the pharmacology of intrathecal baclofen as well as customary approach for utilization of this targeted drug delivery concept. Following these descriptions, four unusual presentations will be described, including the need for initial trialing, patient-directed boluses during chronic intrathecal baclofen therapy, use of medications other than baclofen for intrathecal therapy in spastic patients, and intraventricular baclofen delivery. These hypothetical cases are provided in an effort to expand the use of targeted drug delivery to larger population of spastic patients.
Le texte complet de cet article est disponible en PDF.Keywords : Intrathecal therapy, Intrathecal baclofen, Spasticity, Intraventricular baclofen
Plan
| Disclosure Statement: Speakers bureau, fellowship support and research grant: Medtronic (19107). Speakers bureau, and research grant: Jazz Pharmaceuticals (19107). Speakers bureau: Ipsen. Patent compensation: Saol Therapeutics. |
Vol 29 - N° 3
P. 537-551 - août 2018 Retour au numéro
Article précédent
- Muscle Overactivity in the Upper Motor Neuron Syndrome : Assessment and Problem Solving for Complex Cases: the Role of Physical and Occupational Therapy
- Kimberly Miczak, Joseph Padova
- Neurosurgical Approaches
- Peter J. Madsen, Han-Chiao Isaac Chen, Shih-Shan Lang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?